Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3356152
Max Phase: Preclinical
Molecular Formula: C20H28F3N3O3
Molecular Weight: 301.43
Molecule Type: Small molecule
Associated Items:
ID: ALA3356152
Max Phase: Preclinical
Molecular Formula: C20H28F3N3O3
Molecular Weight: 301.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOCC[C@H]1C[C@@H]1c1cncc(N2C[C@H]3CNC[C@H]3C2)c1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C18H27N3O.C2HF3O2/c1-2-22-4-3-13-6-18(13)14-5-17(10-20-7-14)21-11-15-8-19-9-16(15)12-21;3-2(4,5)1(6)7/h5,7,10,13,15-16,18-19H,2-4,6,8-9,11-12H2,1H3;(H,6,7)/t13-,15-,16+,18-;/m0./s1
Standard InChI Key: JNLSCODRHBNQPH-QHIYURPZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 301.43 | Molecular Weight (Monoisotopic): 301.2154 | AlogP: 2.27 | #Rotatable Bonds: 6 |
Polar Surface Area: 37.39 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 11.12 | CX LogP: 1.13 | CX LogD: -2.00 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.82 | Np Likeness Score: -0.11 |
1. Onajole OK, Eaton JB, Lukas RJ, Brunner D, Thiede L, Caldarone BJ, Kozikowski AP.. (2014) Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR Ligands., 5 (11): [PMID:25408831] [10.1021/ml500129k] |
Source(1):